Solvay Past Earnings Performance
Past criteria checks 0/6
Solvay has been growing earnings at an average annual rate of 26.4%, while the Chemicals industry saw earnings growing at 6.9% annually. Revenues have been declining at an average rate of 16.6% per year.
Key information
26.4%
Earnings growth rate
26.4%
EPS growth rate
Chemicals Industry Growth | 23.2% |
Revenue growth rate | -16.6% |
Return on equity | -4.4% |
Net Margin | -1.2% |
Next Earnings Update | 06 Mar 2025 |
Recent past performance updates
Recent updates
Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Oct 17Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?
Sep 18Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk
Aug 28Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point
Aug 08Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet
Jul 14Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?
Jun 14Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
May 29Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Apr 24Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market
Mar 10Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?
Nov 20Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13
Nov 06The Return Trends At Solvay (EBR:SOLB) Look Promising
Nov 02Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Oct 19Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
Aug 16Returns At Solvay (EBR:SOLB) Are On The Way Up
Aug 02Is Solvay (EBR:SOLB) A Risky Investment?
Jul 19An Intrinsic Calculation For Solvay SA (EBR:SOLB) Suggests It's 26% Undervalued
Jul 06Solvay's (EBR:SOLB) Dividend Will Be Increased To €1.76
May 11Is Solvay SA (EBR:SOLB) Potentially Undervalued?
May 09Solvay's (EBR:SOLB) Returns On Capital Are Heading Higher
Apr 25Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Apr 09Is There An Opportunity With Solvay SA's (EBR:SOLB) 21% Undervaluation?
Mar 27Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.76
Feb 27Solvay (EBR:SOLB) Has Announced That It Will Be Increasing Its Dividend To €1.08
Jan 09The Return Trends At Solvay (EBR:SOLB) Look Promising
Jan 05Solvay's (EBR:SOLB) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 20Solvay (EBR:SOLB) Seems To Use Debt Quite Sensibly
Dec 18At €94.20, Is Solvay SA (EBR:SOLB) Worth Looking At Closely?
Dec 02Solvay's (EBR:SOLB) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 17Solvay SA (EBR:SOLB) Shares Could Be 34% Below Their Intrinsic Value Estimate
Sep 13New Forecasts: Here's What Analysts Think The Future Holds For Solvay SA (EBR:SOLB)
Aug 07Is Now An Opportune Moment To Examine Solvay SA (EBR:SOLB)?
Jul 28We Think Solvay (EBR:SOLB) Can Stay On Top Of Its Debt
Jul 10Revenue & Expenses Breakdown
How Solvay makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 5,217 | -64 | 471 | 41 |
30 Jun 24 | 5,337 | 18 | 484 | 43 |
31 Mar 24 | 5,570 | 127 | 510 | 45 |
31 Dec 23 | 6,024 | -37 | 552 | 47 |
30 Sep 23 | 497 | -384 | -83 | -187 |
30 Jun 23 | 3,542 | -34 | 146 | -98 |
31 Mar 23 | 6,038 | 495 | 377 | -23 |
31 Dec 22 | 7,979 | 889 | 565 | 46 |
30 Sep 22 | 15,442 | 1,859 | 1,384 | 350 |
30 Jun 22 | 13,895 | 1,659 | 1,342 | 324 |
31 Mar 22 | 12,523 | 1,176 | 1,274 | 310 |
31 Dec 21 | 11,434 | 943 | 1,233 | 325 |
30 Sep 21 | 10,575 | 648 | 1,208 | 316 |
30 Jun 21 | 9,982 | 608 | 1,188 | 314 |
31 Mar 21 | 9,631 | -1,168 | 1,172 | 316 |
31 Dec 20 | 9,714 | -1,125 | 1,212 | 300 |
30 Sep 20 | 10,006 | -1,216 | 1,224 | 309 |
30 Jun 20 | 10,514 | -1,872 | 1,256 | 315 |
31 Mar 20 | 11,055 | -134 | 1,320 | 322 |
31 Dec 19 | 11,227 | -118 | 1,331 | 323 |
30 Sep 19 | 11,347 | 111 | 1,355 | 316 |
30 Jun 19 | 11,409 | 764 | 1,378 | 315 |
31 Mar 19 | 11,349 | 767 | 1,392 | 306 |
31 Dec 18 | 11,299 | 676 | 1,379 | 297 |
30 Sep 18 | 11,187 | 775 | 1,399 | 298 |
30 Jun 18 | 10,987 | 748 | 1,397 | 288 |
31 Mar 18 | 10,953 | 730 | 1,413 | 288 |
31 Dec 17 | 10,984 | 820 | 1,437 | 290 |
30 Sep 17 | 10,851 | 771 | 1,416 | 283 |
30 Jun 17 | 10,694 | 765 | 1,409 | 285 |
31 Mar 17 | 10,057 | 717 | 1,359 | 279 |
31 Dec 16 | 10,044 | 539 | 1,363 | 284 |
30 Sep 16 | 9,168 | 317 | 1,320 | 277 |
30 Jun 16 | 9,512 | 248 | 1,315 | 276 |
31 Mar 16 | 10,146 | 220 | 1,337 | 281 |
31 Dec 15 | 10,083 | 355 | 1,296 | 271 |
30 Sep 15 | 11,068 | 325 | 1,321 | 270 |
30 Jun 15 | 10,929 | 311 | 1,297 | 265 |
31 Mar 15 | 10,793 | 376 | 1,254 | 257 |
31 Dec 14 | 10,629 | 326 | 1,225 | 247 |
30 Sep 14 | 10,425 | 317 | 1,193 | 238 |
30 Jun 14 | 10,222 | 298 | 1,182 | 237 |
31 Mar 14 | 10,086 | 182 | 1,166 | 240 |
31 Dec 13 | 10,150 | 164 | 1,189 | 238 |
Quality Earnings: SOLB is currently unprofitable.
Growing Profit Margin: SOLB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SOLB is unprofitable, but has reduced losses over the past 5 years at a rate of 26.4% per year.
Accelerating Growth: Unable to compare SOLB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SOLB is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).
Return on Equity
High ROE: SOLB has a negative Return on Equity (-4.37%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 18:53 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Solvay SA is covered by 49 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Mutlu Gundogan | ABN AMRO Bank N.V. |
Martin Schnee | AlphaValue |
Volker Bosse | Baader Helvea Equity Research |